Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma The University of Texas, MD Anderson Cancer Center, Houston, Texas Australia
Scientia Clinical Research, Randwick, New South Wales Cancer Care Wollongong, Wollongong, New South Wales Southern Oncology Clinical Research Unit, Adelaide, South Australia